Skip to content

Study to check the safety and performance of the EYECRYL PLUS ASHFY600 lens in participants undergoing cataract surgery

A Prospective, single arm, multicenter, clinical study of EYECRYL PLUS (ASHFY600) intraocular lens to assess the performance and safety in patients undergoing cataract surgery. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092306
Enrollment
375
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: EYECRYL PLUS (ASHFY600) intraocular lens: Total duration of study is 24 months, visit schedule is Pre-operative Visit/Screening Visit Surgery Visit Post-operative 1 to 2 Days Post-ope

Sponsors

Biotech vision care pvt ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 18 year or greater 2 Cataract 3 Calculated IOL power is within the range of the investigational IOL. 4 Given consent to use device related data for scientific purpose 5 Clear intraocular media other than cataract 6 Patient willing to participate and sign informed consent to participate in study and to use device related data for scientific purpose 7 Patient willing to come for all post-operative follow-up

Exclusion criteria

Exclusion criteria: 1 Previous intraocular or corneal surgery 2 Traumatic cataract 3 Pregnancy or lactation 4 Concurrent participation or participation in the last 30 days in any other clinical trial 5 Irregular astigmatism 6 Instability of keratometry or biometry measurements 7 Vulnerable subject. 8 Patients receiving chloroquine treatment. 9 Patient having Microphthalmia. 10 Patient having Chronic Uveitis

Design outcomes

Primary

MeasureTime frame
Percentage of subject achieving distance corrected visual acuity of 0.3 logMAR or better at 12 months post operatively.Timepoint: 12 Month Post operatively

Secondary

MeasureTime frame
Percentage of best-case subjects achieving best corrected distance visual acuity of 0.3 logMAR or better at 12 months post operatively.Timepoint: 12 Month Post operatively

Countries

India

Contacts

Public ContactMR BHARGAV JOSHI

BIOTECH VISION CARE PVT LTD

bhargav.joshi@biotechhealthcare.com09925925667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026